Journal ArticleOPEN ACCESS

Clinical efficacy of dupilumab in the treatment of severe chronic rhinosinusitis: The first case outside of a clinical trial

Clinical Case Reports (2021) 9(3) 1428-1432
DOI: 10.1002/ccr3.3792
12Citations
Citations of this article
21Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Treatment options for severe CRSwNP are limited. Dupilumab is a safe, well-tolerated, and effective alternative in patients with poor control of symptoms, corticosteroid-dependent disease, and high rates of recurrence of nasal polyps after surgery.

Author supplied keywords

Cite

CITATION STYLE

APA

Trimarchi, M., Indelicato, P., Vinciguerra, A., & Bussi, M. (2021). Clinical efficacy of dupilumab in the treatment of severe chronic rhinosinusitis: The first case outside of a clinical trial. Clinical Case Reports, 9(3), 1428–1432. https://doi.org/10.1002/ccr3.3792

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free